261 related articles for article (PubMed ID: 20870725)
1. The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression.
West LE; Roy S; Lachmi-Weiner K; Hayashi R; Shi X; Appella E; Kutateladze TG; Gozani O
J Biol Chem; 2010 Nov; 285(48):37725-32. PubMed ID: 20870725
[TBL] [Abstract][Full Text] [Related]
2. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1.
Kalakonda N; Fischle W; Boccuni P; Gurvich N; Hoya-Arias R; Zhao X; Miyata Y; Macgrogan D; Zhang J; Sims JK; Rice JC; Nimer SD
Oncogene; 2008 Jul; 27(31):4293-304. PubMed ID: 18408754
[TBL] [Abstract][Full Text] [Related]
3. Modulation of p53 function by SET8-mediated methylation at lysine 382.
Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
[TBL] [Abstract][Full Text] [Related]
4. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
5. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis.
Dhami GK; Liu H; Galka M; Voss C; Wei R; Muranko K; Kaneko T; Cregan SP; Li L; Li SS
Mol Cell; 2013 May; 50(4):565-76. PubMed ID: 23706821
[TBL] [Abstract][Full Text] [Related]
6. Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure.
Trojer P; Reinberg D
Cell Cycle; 2008 Mar; 7(5):578-85. PubMed ID: 18256536
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger.
Li H; Fischle W; Wang W; Duncan EM; Liang L; Murakami-Ishibe S; Allis CD; Patel DJ
Mol Cell; 2007 Nov; 28(4):677-91. PubMed ID: 18042461
[TBL] [Abstract][Full Text] [Related]
8. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
[TBL] [Abstract][Full Text] [Related]
9. Repression of p53 activity by Smyd2-mediated methylation.
Huang J; Perez-Burgos L; Placek BJ; Sengupta R; Richter M; Dorsey JA; Kubicek S; Opravil S; Jenuwein T; Berger SL
Nature; 2006 Nov; 444(7119):629-32. PubMed ID: 17108971
[TBL] [Abstract][Full Text] [Related]
10. L3MBTL1, a histone-methylation-dependent chromatin lock.
Trojer P; Li G; Sims RJ; Vaquero A; Kalakonda N; Boccuni P; Lee D; Erdjument-Bromage H; Tempst P; Nimer SD; Wang YH; Reinberg D
Cell; 2007 Jun; 129(5):915-28. PubMed ID: 17540172
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53 activity through lysine methylation.
Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
[TBL] [Abstract][Full Text] [Related]
12. L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.
Gurvich N; Perna F; Farina A; Voza F; Menendez S; Hurwitz J; Nimer SD
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22552-7. PubMed ID: 21149733
[TBL] [Abstract][Full Text] [Related]
13. L3MBTL1 recognition of mono- and dimethylated histones.
Min J; Allali-Hassani A; Nady N; Qi C; Ouyang H; Liu Y; MacKenzie F; Vedadi M; Arrowsmith CH
Nat Struct Mol Biol; 2007 Dec; 14(12):1229-30. PubMed ID: 18026117
[TBL] [Abstract][Full Text] [Related]
14. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
15. The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues.
Kudithipudi S; Dhayalan A; Kebede AF; Jeltsch A
Biochimie; 2012 Nov; 94(11):2212-8. PubMed ID: 22583696
[TBL] [Abstract][Full Text] [Related]
16. Chromatin protein L3MBTL1 is dispensable for development and tumor suppression in mice.
Qin J; Van Buren D; Huang HS; Zhong L; Mostoslavsky R; Akbarian S; Hock H
J Biol Chem; 2010 Sep; 285(36):27767-75. PubMed ID: 20592034
[TBL] [Abstract][Full Text] [Related]
17. Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.
Zhang X; Bruice TC
Biochemistry; 2008 Jun; 47(25):6671-7. PubMed ID: 18512960
[TBL] [Abstract][Full Text] [Related]
18. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
[TBL] [Abstract][Full Text] [Related]
19. The histone H4 lysine 20 monomethyl mark, set by PR-Set7 and stabilized by L(3)mbt, is necessary for proper interphase chromatin organization.
Sakaguchi A; Joyce E; Aoki T; Schedl P; Steward R
PLoS One; 2012; 7(9):e45321. PubMed ID: 23024815
[TBL] [Abstract][Full Text] [Related]
20. Structural studies of a four-MBT repeat protein MBTD1.
Eryilmaz J; Pan P; Amaya MF; Allali-Hassani A; Dong A; Adams-Cioaba MA; Mackenzie F; Vedadi M; Min J
PLoS One; 2009 Oct; 4(10):e7274. PubMed ID: 19841675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
